1. Home
  2. CTMX vs LXU Comparison

CTMX vs LXU Comparison

Compare CTMX & LXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • LXU
  • Stock Information
  • Founded
  • CTMX 2008
  • LXU 1968
  • Country
  • CTMX United States
  • LXU United States
  • Employees
  • CTMX N/A
  • LXU N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • LXU Major Chemicals
  • Sector
  • CTMX Health Care
  • LXU Industrials
  • Exchange
  • CTMX Nasdaq
  • LXU Nasdaq
  • Market Cap
  • CTMX 596.2M
  • LXU 612.4M
  • IPO Year
  • CTMX 2015
  • LXU 1969
  • Fundamental
  • Price
  • CTMX $3.64
  • LXU $9.27
  • Analyst Decision
  • CTMX Strong Buy
  • LXU Buy
  • Analyst Count
  • CTMX 6
  • LXU 3
  • Target Price
  • CTMX $6.50
  • LXU $10.17
  • AVG Volume (30 Days)
  • CTMX 3.9M
  • LXU 439.7K
  • Earning Date
  • CTMX 11-06-2025
  • LXU 10-29-2025
  • Dividend Yield
  • CTMX N/A
  • LXU N/A
  • EPS Growth
  • CTMX 50.22
  • LXU N/A
  • EPS
  • CTMX 0.24
  • LXU N/A
  • Revenue
  • CTMX $113,631,000.00
  • LXU $585,065,000.00
  • Revenue This Year
  • CTMX N/A
  • LXU $14.21
  • Revenue Next Year
  • CTMX N/A
  • LXU $0.20
  • P/E Ratio
  • CTMX $15.28
  • LXU N/A
  • Revenue Growth
  • CTMX N/A
  • LXU 12.49
  • 52 Week Low
  • CTMX $0.40
  • LXU $4.88
  • 52 Week High
  • CTMX $4.62
  • LXU $9.98
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 50.34
  • LXU 54.68
  • Support Level
  • CTMX $3.35
  • LXU $8.20
  • Resistance Level
  • CTMX $4.45
  • LXU $9.85
  • Average True Range (ATR)
  • CTMX 0.37
  • LXU 0.50
  • MACD
  • CTMX -0.06
  • LXU 0.05
  • Stochastic Oscillator
  • CTMX 30.00
  • LXU 61.83

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

Share on Social Networks: